Literature DB >> 7926809

Induction of D2 and D3 cyclin-encoding genes during promotion of the G1/S transition by prolactin in rat Nb2 cells.

Y Hosokawa1, T Onga, K Nakashima.   

Abstract

Prolactin has been demonstrated to induce the expression of the genes encoding cyclin D2 and D3 during promotion of the G1/S transition in rat Nb2 pre-T-lymphoma cells. cDNA clones encoding these rat cyclins D2 and D3 were isolated and analyzed.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7926809     DOI： 10.1016/0378-1119(94)90075-2

Source DB:  PubMed          Journal:  Gene        ISSN： 0378-1119            Impact factor:   3.688


  5 in total

Review 1.  Prolactin as a mitogen in mammary cells.

Authors:  R Das; B K Vonderhaar
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-01       Impact factor: 2.673

2.  Aberrant DNA methylation of cyclin D2 and p27 genes in rodent pituitary tumor cell lines correlates with specific gene expression.

Authors:  X Qian; L Jin; R V Lloyd
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

3.  Analysis of prolactin-modulated gene expression profiles during the Nb2 cell cycle using differential screening techniques.

Authors:  C Bole-Feysot; E Perret; P Roustan; B Bouchard; P A Kelly
Journal:  Genome Biol       Date:  2000-10-16       Impact factor: 13.583

4.  MafA is required for postnatal proliferation of pancreatic β-cells.

Authors:  Koki Eto; Wataru Nishimura; Hisashi Oishi; Haruhide Udagawa; Miho Kawaguchi; Masaki Hiramoto; Toshiyoshi Fujiwara; Satoru Takahashi; Kazuki Yasuda
Journal:  PLoS One       Date:  2014-08-15       Impact factor: 3.240

5.  BAP18 is involved in upregulation of CCND1/2 transcription to promote cell growth in oral squamous cell carcinoma.

Authors:  Xue Wang; Chunyu Wang; Guangqi Yan; Yuanyuan Kang; Ge Sun; Shengli Wang; Renlong Zou; Hongmiao Sun; Kai Zeng; Huijuan Song; Wei Liu; Ning Sun; Wensu Liu; Yue Zhao
Journal:  EBioMedicine       Date:  2020-02-27       Impact factor: 8.143
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.